From the CRC network, only ASCL1 emerged from this analysis, given its different dynamic expression during murine TH-MYCN-driven tumor formation compared to HAND2, PHOX2B, GATA3 and ISL1 (see Figure 3E). The gene discussed is ASCL1; the disease is neoplasm.